Anticoagulant Use for Prevention of Stroke in a Commercial Population with Atrial Fibrillation

BACKGROUND: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, and patients with AF are at an increased risk for stroke. Thromboprophylaxis with vitamin K antagonists reduces the annual incidence of stroke by approximately 60%, but appropriate thromboprophylaxis is prescribed...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Patel, Aarti A., Lennert, Barb, Macomson, Brian, Nelson, Winnie W., Owens, Gary M., Mody, Samir H., Schein, Jeff
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Engage Healthcare Communications, LLC 2012
Gaiak:
Clinical
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4046452/
https://ncbi.nlm.nih.gov/pubmed/24991327
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak